Finance.Foundation
Comparison · seed-0.6 · 2026-08-29

Johnson & Johnson (JNJ) vs Merck & Co. (MRK)

Johnson & Johnson (JNJ) and Merck & Co. (MRK) side by side: both in Healthcare, both listed on New York Stock Exchange. Johnson & Johnson is the larger of the two by approximate market capitalization (about 1.5×).

FieldJohnson & JohnsonMerck & Co.
Legal nameJohnson & JohnsonMerck & Co., Inc.
TickerJNJMRK
ExchangeNew York Stock Exchange XNYSNew York Stock Exchange XNYS
JurisdictionUnited StatesUnited States
SectorHealthcareHealthcare
IndustryPharma & MedTechPharmaceuticals
Market cap ≈$380bn$250bn
Founded18861891
Reporting currencyUSDUSD
LEI549300G0CFPGEF6X20434YV9Y5M8S0BRK1RP0397
ISINUS4781601046US58933Y1055
FIGIBBG001S5SHQ9BBG001S5TC52
Index membershipS&P 500S&P 500
Held by (covered funds)

Johnson & Johnson

Diversified healthcare: innovative medicines and medical devices.

Full profile →

Merck & Co.

US pharmaceutical major (known as MSD outside North America) whose cancer immunotherapy Keytruda is among the world's best-selling drugs; also strong in vaccines and animal health.

Full profile →

What they share

Same indices: S&P 500

Approximate reference values (seed-0.6 · 2026-08-29) — not real-time, not investment advice. Both sides as data: /api/v1/companies/johnson-johnson · /api/v1/companies/merck